DDX21 and cancer: We investigated DDX21 protein expression in 710 colorectal cancer cases using tissue microarrays, which included a large cohort of 619 patients with early stage (stages I and II) cancer (Table 1) and a cohort of 91 patients with late stage (stages III and IV) cancer (Table 2).